BRKR
Bruker·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Ample Liquidity
Significant Net Income Decline
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BRKR
Bruker Corporation
A developer of life science and materials research systems based on X-ray, mass spectrometry, and spectroscopy technologies
Healthcare Equipment and Supplies
--
08/04/2000
NASDAQ Stock Exchange
11,396
12-31
Common stock
40 Manning Road, Billerica, MA 01821
--
Bruker Corporation is incorporated in Delaware. The company is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at the microscopic, molecular and cellular levels. Many of the company's products are used to detect, measure and visualize structural features of chemical, biological and industrial material samples. The company's products and solutions meet the rapidly growing needs of various customers in the fields of life science research, pharmaceuticals, biotechnology, applied markets, cell biology, clinical research, microbiology, in vitro diagnosis, nanotechnology and materials science research.
Earnings Call
Company Financials
EPS
BRKR has released its 2025 Q3 earnings. EPS was reported at 0.45, versus the expected 0.32, beating expectations. The chart below visualizes how BRKR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BRKR has released its 2025 Q3 earnings report, with revenue of 860.50M, reflecting a YoY change of -0.45%, and net profit of -58.50M, showing a YoY change of -245.16%. The Sankey diagram below clearly presents BRKR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



